Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · IEX Real-Time Price · USD
1.280
+0.080 (6.67%)
At close: Jul 2, 2024, 4:00 PM
1.270
-0.010 (-0.78%)
After-hours: Jul 2, 2024, 7:59 PM EDT
PACB Stock Forecast
PACB's stock price has decreased by -90.07% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 11 analysts with 12-month price forecasts for PACB stock have an average target of 6.59, with a low estimate of 2.00 and a high estimate of 15. The average target predicts an increase of 414.84% from the current stock price of 1.28.
Analyst Consensus: Buy
* Price targets were last updated on May 15, 2024.
Analyst Ratings
The average analyst rating for PACB stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 4 | 4 |
| Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Hold | 5 | 5 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 14 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jun 3, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $4 | Hold | Maintains | $10 → $4 | +212.50% | May 15, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $6.5 → $2 | Hold | Maintains | $6.5 → $2 | +56.25% | May 13, 2024 |
| Barclays | Barclays | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | +56.25% | May 10, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 22, 2024 |
Financial Forecast
Revenue This Year
183.94M
from 200.52M
Decreased by -8.27%
Revenue Next Year
244.82M
from 183.94M
Increased by 33.10%
EPS This Year
-0.93
from -1.21
EPS Next Year
-0.75
from -0.93
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 197.2M | 331.8M | 451.7M | 461.0M | 548.6M |
| Avg | 183.9M | 244.8M | 330.9M | 386.6M | 441.0M |
| Low | 163.9M | 197.7M | 255.2M | 295.3M | 332.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.7% | 80.4% | 84.5% | 39.3% | 41.9% |
| Avg | -8.3% | 33.1% | 35.1% | 16.9% | 14.1% |
| Low | -18.3% | 7.5% | 4.2% | -10.8% | -13.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.88 | -0.64 | -0.38 | -0.26 | -0.21 |
| Avg | -0.93 | -0.75 | -0.56 | -0.39 | -0.31 |
| Low | -1.07 | -0.89 | -0.70 | -0.49 | -0.42 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.